Showing results (431-440 of 520) with videos related to
Sort By:
Pageof 52
Cardiovascular & Hematological Agents in Medicinal Chemistry|January 20, 2009
mTOR in growth and protection of hypertrophying myocardiumSundaravadivel Balasubramanian, Rebecca K Johnston, Phillip C Moschella, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|January 20, 2009
Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targetsE Zorio, P Medina, J Rueda, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|November 6, 2007
Inhibition of renin-angiotensin system and advanced glycation end products formation: a promising therapeutic approach targeting on cardiovascular diseasesA Geronikaki, A Gavalas, V Dislian, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|November 6, 2007
Preclinical testing of drug-induced proarrhythmia: value of transgenic modelsL Fabritz, G Breithardt, P KirchhofCardiovascular & Hematological Agents in Medicinal Chemistry|November 6, 2007
Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic strokeSomnath Mukhopadhyay, David A TulisCardiovascular & Hematological Agents in Medicinal Chemistry|February 3, 2007
Structure-activity relationship studies on ADAM protein-integrin interactionsX Lu, D Lu, M F Scully, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|February 3, 2007
Glibenclamide action on myocardial function and arrhythmia incidence in the healthy and diabetic heartJ A Negroni, E C Lascano, H F del ValleCardiovascular & Hematological Agents in Medicinal Chemistry|November 1, 2006
Cellular mechanisms of the protective effect of polyphenols on the neurovascular unit in strokesY Curin, M F Ritz, R AndriantsitohainaCardiovascular & Hematological Agents in Medicinal Chemistry|November 1, 2006
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicineM Buemi, L Nostro, A Romeo, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|November 1, 2006
Retrometabolic syntheses of astaxanthin (3,3'-dihydroxy-beta,beta-carotene-4,4'-dione) conjugates: a novel approach to oral and parenteral cardio-protectionSamuel F Lockwood, Henry L Jackson, Garrett J GrossPageof 52